** Shares of Fisher & Paykel Healthcare Corporation FPH.NZ fall 4.8% to NZ$33.4
** Stock down as much as 7.1%, hits lowest level since March 25
** The medical equipment maker says costs would likely increase for FY26 due to the new U.S. tariffs
** The U.S. tariffs may add to co's timeframe to achieve its gross margin target, co adds
** However, co doesn't anticipate material impact from U.S. tariffs on its net profit after tax for FY2025
** Stock down 8.6% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。